Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroesophageal Reflux | 8 | 2024 | 237 | 3.230 |
Why?
|
| Surgeons | 6 | 2022 | 340 | 1.430 |
Why?
|
| Deglutition Disorders | 5 | 2023 | 154 | 1.340 |
Why?
|
| Fundoplication | 5 | 2024 | 52 | 1.280 |
Why?
|
| Hernia, Hiatal | 2 | 2024 | 39 | 1.010 |
Why?
|
| Myotomy | 2 | 2023 | 15 | 0.940 |
Why?
|
| Laparoscopy | 4 | 2024 | 481 | 0.930 |
Why?
|
| Natural Orifice Endoscopic Surgery | 2 | 2023 | 35 | 0.930 |
Why?
|
| Esophageal Achalasia | 1 | 2022 | 29 | 0.730 |
Why?
|
| Clinical Coding | 1 | 2019 | 29 | 0.580 |
Why?
|
| Standard of Care | 1 | 2019 | 81 | 0.560 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 364 | 0.530 |
Why?
|
| Communication | 4 | 2022 | 977 | 0.510 |
Why?
|
| Breast | 2 | 2015 | 156 | 0.460 |
Why?
|
| Organ Transplantation | 1 | 2019 | 253 | 0.460 |
Why?
|
| Renal Dialysis | 1 | 2020 | 466 | 0.450 |
Why?
|
| Phenotype | 1 | 2024 | 3170 | 0.450 |
Why?
|
| Tissue Donors | 1 | 2019 | 420 | 0.450 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2019 | 339 | 0.450 |
Why?
|
| Family | 2 | 2020 | 685 | 0.440 |
Why?
|
| Tissue and Organ Procurement | 1 | 2019 | 343 | 0.430 |
Why?
|
| Decision Making | 2 | 2020 | 982 | 0.430 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 390 | 0.420 |
Why?
|
| Gastroplasty | 2 | 2024 | 32 | 0.410 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 599 | 0.400 |
Why?
|
| Burnout, Professional | 1 | 2020 | 488 | 0.400 |
Why?
|
| Esophageal Motility Disorders | 2 | 2024 | 30 | 0.400 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 962 | 0.380 |
Why?
|
| Treatment Outcome | 10 | 2025 | 11793 | 0.370 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 185 | 0.360 |
Why?
|
| Health Personnel | 1 | 2019 | 757 | 0.360 |
Why?
|
| Aged | 14 | 2025 | 26215 | 0.350 |
Why?
|
| Quality of Life | 7 | 2024 | 3210 | 0.320 |
Why?
|
| Texas | 3 | 2021 | 273 | 0.270 |
Why?
|
| Humans | 25 | 2025 | 145763 | 0.230 |
Why?
|
| Obesity, Morbid | 3 | 2024 | 293 | 0.230 |
Why?
|
| Dilatation | 2 | 2023 | 73 | 0.230 |
Why?
|
| Gastric Emptying | 1 | 2024 | 36 | 0.210 |
Why?
|
| Zenker Diverticulum | 1 | 2023 | 12 | 0.200 |
Why?
|
| Thrombelastography | 1 | 2025 | 192 | 0.200 |
Why?
|
| Middle Aged | 8 | 2025 | 36302 | 0.200 |
Why?
|
| Postoperative Complications | 3 | 2025 | 2977 | 0.200 |
Why?
|
| Esophagitis | 1 | 2023 | 67 | 0.190 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2022 | 14 | 0.190 |
Why?
|
| Gastrectomy | 1 | 2024 | 166 | 0.180 |
Why?
|
| Pancreatectomy | 1 | 2025 | 289 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2024 | 333 | 0.180 |
Why?
|
| Gastric Bypass | 1 | 2023 | 126 | 0.180 |
Why?
|
| Retrospective Studies | 7 | 2024 | 17325 | 0.180 |
Why?
|
| Oregon | 1 | 2021 | 77 | 0.170 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2025 | 293 | 0.170 |
Why?
|
| Preoperative Care | 2 | 2025 | 380 | 0.170 |
Why?
|
| Wisconsin | 1 | 2021 | 100 | 0.170 |
Why?
|
| Evaluation Studies as Topic | 1 | 2021 | 164 | 0.170 |
Why?
|
| Bariatric Surgery | 1 | 2025 | 253 | 0.170 |
Why?
|
| Esophagus | 1 | 2023 | 262 | 0.170 |
Why?
|
| Venous Thromboembolism | 1 | 2025 | 328 | 0.160 |
Why?
|
| Recurrence | 1 | 2024 | 1139 | 0.160 |
Why?
|
| Female | 11 | 2025 | 79035 | 0.160 |
Why?
|
| Pamphlets | 1 | 2020 | 26 | 0.150 |
Why?
|
| Precision Medicine | 1 | 2024 | 461 | 0.150 |
Why?
|
| Male | 10 | 2025 | 73003 | 0.150 |
Why?
|
| Morals | 1 | 2020 | 79 | 0.150 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 6085 | 0.150 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2024 | 498 | 0.150 |
Why?
|
| Patient Participation | 2 | 2022 | 446 | 0.150 |
Why?
|
| Electric Impedance | 3 | 2023 | 108 | 0.140 |
Why?
|
| Sex Factors | 1 | 2024 | 2110 | 0.130 |
Why?
|
| History, 20th Century | 1 | 2019 | 328 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 928 | 0.120 |
Why?
|
| Prospective Studies | 6 | 2025 | 8075 | 0.120 |
Why?
|
| Adult | 6 | 2025 | 40872 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 1420 | 0.120 |
Why?
|
| Obesity | 3 | 2024 | 3118 | 0.120 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 719 | 0.110 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2015 | 189 | 0.110 |
Why?
|
| Intensive Care Units | 1 | 2021 | 924 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2019 | 411 | 0.110 |
Why?
|
| Health Facilities | 1 | 2015 | 85 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 777 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2020 | 1897 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 1197 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 8346 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2022 | 1269 | 0.080 |
Why?
|
| Qualitative Research | 1 | 2019 | 1683 | 0.080 |
Why?
|
| Prognosis | 1 | 2019 | 4329 | 0.080 |
Why?
|
| Physician-Patient Relations | 2 | 2025 | 588 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2025 | 85 | 0.050 |
Why?
|
| von Willebrand Factor | 1 | 2025 | 85 | 0.050 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2025 | 92 | 0.050 |
Why?
|
| Gastroscopy | 1 | 2024 | 18 | 0.050 |
Why?
|
| Manometry | 1 | 2023 | 98 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 423 | 0.050 |
Why?
|
| Proton Pump Inhibitors | 1 | 2023 | 109 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2023 | 360 | 0.050 |
Why?
|
| Nitriles | 1 | 2023 | 211 | 0.040 |
Why?
|
| Consensus | 1 | 2024 | 479 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2023 | 223 | 0.040 |
Why?
|
| Time Factors | 1 | 2013 | 7133 | 0.040 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2023 | 237 | 0.040 |
Why?
|
| Operating Rooms | 1 | 2022 | 144 | 0.040 |
Why?
|
| Comorbidity | 1 | 2024 | 1662 | 0.040 |
Why?
|
| Weight Loss | 1 | 2024 | 859 | 0.030 |
Why?
|
| Length of Stay | 1 | 2024 | 1350 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2022 | 868 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2025 | 3752 | 0.030 |
Why?
|
| Biomarkers | 1 | 2025 | 4302 | 0.020 |
Why?
|
| Biopsy | 1 | 2015 | 1082 | 0.020 |
Why?
|
| United States | 2 | 2020 | 16123 | 0.020 |
Why?
|
| Medicare | 1 | 2015 | 904 | 0.020 |
Why?
|
| Young Adult | 1 | 2022 | 14251 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2015 | 6032 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2393 | 0.010 |
Why?
|